After Idorsia’s former chief, Srishti Gupta, M.D., left the company upon “mutual agreement” in March, the Swiss drugmaker has now tapped a new leader, Roland Wandeler, Ph.D. Wandeler will officially take over from interim CEO and board chairman Jean-Paul Clozel, M.D., come October 1.
Source: FierceBiotech
